Palvella Therapeutics, Inc. · NASDAQ:PVLA
Goin Kathleen sold 4,313 Palvella Therapeutics, Inc. shares (Form 4)
Traded Oct 21, 2026 · Filed Oct 23, 2026
On Oct 21, 2026, Goin Kathleen (Chief Operating Officer) sold 4,313 Palvella Therapeutics, Inc. shares at an average US$124.58 for US$537K under a trading plan, leaving 0 shares. Filed Oct 23, 2026 (Form 4).
- Sold
- 4,313 shares
- Price
- US$124.58 average (US$123.62 to US$126.19)
- Value
- US$537K
- Holding after
- 0 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Chief Operating Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 21, 2026 | Common Stock | Option exercise | 2,165 | US$7.14 | 2,165 | Direct |
| Oct 21, 2026 | Common Stock | Option exercise | 2,148 | US$9.08 | 4,313 | Direct |
| Oct 21, 2026 | Common Stock | Sale | 2,043 | US$123.62 | 2,270 | Direct |
| Oct 21, 2026 | Common Stock | Sale | 1,663 | US$125.16 | 607 | Direct |
| Oct 21, 2026 | Common Stock | Sale | 607 | US$126.19 | 0 | Direct |
Source
Download original · View original at SEC
Related
- Palvella Therapeutics, Inc.
- Goin Kathleen
- Palvella Therapeutics, Inc. shareholders
- Form 4 · Goin Kathleen · Sep 18, 2026
- Form 4 · Goin Kathleen · Aug 20, 2026
- Form 4 · Goin Kathleen · Jul 17, 2026
- Form 4 · Goin Kathleen · Jun 22, 2026
- Form 4 · Goin Kathleen · May 22, 2026
- Form 4 · Jenkins George M · Oct 14, 2026
- Form 4 · Jenkins George M · Sep 15, 2026
- Form 4 · Kiritsy Christopher P · Sep 4, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026
- Schedule 13G/A · First Light Asset Management, LLC · Aug 14, 2026